Complete Filing Data
Blaize Holdings, Inc. reported Stockholders Equity of $39.00 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Blaize Holdings, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income * | -$206.9M | -$61.2M | $1.3M | $1.7M |
| Revenue * | $38.6M | $1.6M | ||
| Operating Income Loss | -$103.8M | -$47.6M | -$3.4M | -$1.5M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$206.7M | -$62.1M | $2.4M | $2.5M |
| Nonoperating Income Expense | -$102.8M | -$14.5M | $5.8M | $4.0M |
| Income Tax Expense Benefit | $217.0K | -$952.0K | $1.0M | $791.8K |
| Accrued Income Taxes Current | $1.0M | $791.8K | ||
| Research And Development Expense | $42.5M | $25.1M | ||
| Other Nonoperating Income Expense | $992.0K | $1.2M | ||
| Selling General And Administrative Expense | ||||
| Income Taxes Paid Net | $337.0K | $223.0K | $791.8K | |
| Deferred Income Tax Expense Benefit | -$368.0K | -$1.1M | ||
| Deferred Income Tax Assets Net | $2.1M | $2.2M | ||
| Cost Of Revenue | $32.4M | $579.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$26.3M | -$29.6M | -$147.8M | -$25.6M | -$12.2M | -$16.7M | $3.4K | $98.8K | $1.6M | $661.9K | $93.3K | -$96.9K | -$500.00 | $0.00 | |
| Revenue * | $11.9M | $2.0M | $1.0M | $781.0K | $223.0K | $549.0K | |||||||||
| Operating Income Loss | -$22.6M | -$21.9M | -$38.0M | -$11.4M | -$11.1M | -$8.1M | -$727.7K | -$556.5K | -$895.8K | -$402.5K | -$220.0K | -$126.3K | -$500.00 | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$26.2M | -$29.6M | -$147.6M | -$25.6M | -$12.0M | -$16.6M | $182.7K | $267.2K | $2.2M | $914.6K | $174.0K | -$96.9K | -$500.00 | ||
| Nonoperating Income Expense | -$3.7M | -$7.7M | -$109.6M | -$14.2M | -$887.0K | -$8.4M | $910.4K | $823.7K | $3.1M | $1.3M | $394.0K | $29.4K | |||
| Income Tax Expense Benefit | $21.0K | $39.0K | $162.0K | $55.0K | $131.0K | $162.0K | $179.3K | $168.5K | $605.1K | $252.7K | $80.7K | ||||
| Accrued Income Taxes Current | $2.5M | $2.4M | $2.5M | $2.1M | $406.1K | $283.8K | $162.9K | $952.9K | $1.6M | $1.4M | $333.4K | $80.7K | |||
| Research And Development Expense | $9.7M | $9.6M | $13.1M | $5.8M | $5.9M | $4.1M | |||||||||
| Other Nonoperating Income Expense | $241.0K | -$73.0K | -$19.0K | $1.3M | $633.0K | -$229.0K | |||||||||
| Selling General And Administrative Expense | $14.3M | $13.0M | $13.4M | $5.5M | $5.0M | $4.0M | |||||||||
| Income Taxes Paid Net | $129.0K | $60.0K | |||||||||||||
| Deferred Income Tax Expense Benefit | -$10.0K | -$23.0K | |||||||||||||
| Deferred Income Tax Assets Net | $2.4M | $2.2M | $2.2M | ||||||||||||
| Cost Of Revenue |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity | $39.0M | -$110.5M | -$53.2M | -$10.1M | -$8.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $46.1M | $50.5M | $3.2M | $22.2K | $1.5M |
| Cash And Cash Equivalents At Carrying Value | $45.8M | $50.2M | $0.00 | $22.2K | $1.5M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$84.5K | $821.1K | -$1.5M | ||
| Retained Earnings Accumulated Deficit | -$636.2M | -$429.3M | -$15.8M | -$10.1M | -$8.8M |
| Liabilities Current | $43.4M | $186.1M | $31.4M | $1.3M | $700.0K |
| Liabilities And Stockholders Equity | $102.2M | $78.5M | $72.6M | $296.0M | $293.7M |
| Liabilities | $63.2M | $189.0M | $41.4M | $11.4M | $10.8M |
| Assets Current | $96.6M | $71.7M | $25.7M | $208.8K | $1.9M |
| Assets | $102.2M | $78.5M | $72.6M | $296.0M | $293.7M |
| Temporary Equity Accretion To Redemption Value Adjustment | $3.4M | $4.5M | $3.0M | ||
| Deferred Offering Costs Noncurrent | $10.1M | $10.1M | $10.1M | $10.1M | |
| Restricted Cash Current | $757.3K | $843.3K | $0.00 | ||
| Assets Held In Trust Noncurrent | $47.6M | $46.9M | $295.8M | $291.8M | |
| Other Assets Noncurrent | $739.0K | $815.0K | $61.7K | ||
| Temporary Equity Accretion To Redemption Value | $3.4M | $4.5M | $3.0M | ||
| Prepaid Expense And Other Assets Current | $4.0M | $12.6M | |||
| Franchise Tax Payable | $200.0K | $35.8K | $200.0K | $11.1K | |
| Property Plant And Equipment Net | $1.2M | $2.1M | |||
| Other Liabilities Noncurrent | $1.3M | $1.7M | |||
| Operating Lease Right Of Use Asset | $1.5M | $1.8M | |||
| Operating Lease Liability Noncurrent | $804.0K | $1.2M | |||
| Operating Lease Liability Current | $644.0K | $578.0K | |||
| Inventory Net | $10.1M | $8.6M | |||
| Common Stock Value | $12.0K | $5.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $1.3M | -$4.8M | $16.7M | -$106.6M | -$81.4M | -$69.6M | -$14.3M | -$13.6M | -$13.1M | -$9.4M | -$9.1M | -$8.9M | $24.5K | $24.5K | $0.00 |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $24.3M | $28.9M | $45.2M | $68.6M | $87.4M | $7.0M | $358.00 | $1.3M | $1.2M | $480.3K | $621.6K | $927.4K | $25.1K | $25.1K | |
| Cash And Cash Equivalents At Carrying Value | $24.0M | $28.6M | $45.0M | $68.6M | $87.4M | $7.0M | $358.00 | $1.3M | $1.2M | $480.3K | $621.6K | $927.4K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$5.3M | $3.8M | $1.2M | -$612.1K | $25.1K | ||||||||||
| Retained Earnings Accumulated Deficit | -$632.9M | -$606.6M | -$577.0M | -$19.8M | -$18.1M | -$16.7M | -$14.3M | -$13.6M | -$13.1M | -$9.4M | -$9.1M | -$8.9M | |||
| Liabilities Current | $36.8M | $39.6M | $38.4M | $10.4M | $8.5M | $6.9M | $4.5M | $4.9M | $4.6M | $622.5K | $209.6K | $231.9K | |||
| Liabilities And Stockholders Equity | $60.9M | $53.8M | $100.2M | $50.1M | $49.1M | $48.1M | $70.9M | $71.3M | $70.8M | $294.3M | $293.2M | $293.2M | |||
| Liabilities | $59.6M | $58.6M | $50.4M | $20.4M | $18.5M | $17.0M | $14.6M | $15.0M | $14.6M | $10.7M | $10.3M | $10.3M | |||
| Assets Current | $54.8M | $47.4M | $93.5M | $192.8K | $181.6K | $280.4K | $57.0K | $1.4M | $1.4M | $734.1K | $925.6K | $1.2M | |||
| Assets | $60.9M | $53.8M | $100.2M | $50.1M | $49.1M | $48.1M | $70.9M | $71.3M | $70.8M | $294.3M | $293.2M | $293.2M | |||
| Temporary Equity Accretion To Redemption Value Adjustment | $857.2K | $846.1K | $800.0K | $681.1K | $605.2K | $2.3M | $942.4K | $301.6K | |||||||
| Deferred Offering Costs Noncurrent | $10.1M | $10.1M | $10.1M | $10.1M | $10.1M | $10.1M | $10.1M | $10.1M | $10.1M | ||||||
| Restricted Cash Current | $66.6K | $26.9K | $148.7K | ||||||||||||
| Assets Held In Trust Noncurrent | $49.9M | $48.9M | $47.9M | $70.8M | $69.9M | $69.4M | $293.6M | $292.2M | $291.8M | ||||||
| Other Assets Noncurrent | $802.0K | $1.1M | $815.0K | $33.9K | $84.8K | $141.6K | |||||||||
| Temporary Equity Accretion To Redemption Value | $800.0K | $2.3M | |||||||||||||
| Prepaid Expense And Other Assets Current | $8.4M | $6.9M | $5.8M | $56.8K | $45.5K | $102.3K | |||||||||
| Franchise Tax Payable | $150.0K | $100.0K | $92.1K | $100.0K | $50.0K | $150.0K | |||||||||
| Property Plant And Equipment Net | $1.3M | $1.6M | $2.1M | ||||||||||||
| Other Liabilities Noncurrent | $1.3M | $1.3M | $1.4M | ||||||||||||
| Operating Lease Right Of Use Asset | $1.7M | $1.5M | $1.6M | ||||||||||||
| Operating Lease Liability Noncurrent | $948.0K | $928.0K | $1.1M | ||||||||||||
| Operating Lease Liability Current | $678.0K | $502.0K | $542.0K | ||||||||||||
| Inventory Net | $8.8M | $8.2M | $8.4M | ||||||||||||
| Common Stock Value | $11.0K | $10.0K | $10.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$73.8M | -$53.5M | -$2.3M | -$1.4M |
| Net Cash Provided By Used In Financing Activities | $70.1M | $101.7M | -$227.0M | -$144.7K |
| Increase Decrease In Accrued Income Taxes Payable | -$510.5K | $235.9K | $791.8K | |
| Net Cash Provided By Used In Investing Activities | -$788.0K | -$902.0K | $230.1M | |
| Proceeds From Convertible Debt | $0.00 | $110.7M | $810.3K | |
| Cost Of Goods And Service Excluding Depreciation Depletion And Amortization | ||||
| Share Based Compensation | $37.5M | $3.8M | ||
| Increase Decrease In Fair Value Of Convertible Notes | ||||
| Increase Decrease In Other Assets | $186.5K | $201.7K | ||
| Payments To Acquire Property Plant And Equipment | $788.0K | $902.0K | ||
| Increase Decrease In Fair Value Of Warrant Liabilities | ||||
| Increase Decrease In Accrued Liabilities | $2.7M | $1.6M | -$232.1K | |
| Increase Decrease In Operating Lease Liability | -$727.0K | -$616.0K | ||
| Increase Decrease In Inventories | $1.6M | $2.0M | ||
| Increase Decrease In Franchise Tax Payable | $200.0K | $35.8K | $188.9K | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$186.5K | |||
| Increase Decrease In Other Operating Liabilities | ||||
| Increase Decrease In Other Operating Assets | ||||
| Increase Decrease In Accrued Compensation |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q1 2023 | Q1 2022 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$15.9M | -$7.4M | -$620.3K | -$556.1K | $100.00 | ||||
| Net Cash Provided By Used In Financing Activities | $11.3M | $11.4M | -$227.7M | -$56.0K | $25.0K | ||||
| Increase Decrease In Accrued Income Taxes Payable | -$95.0K | $100.0K | $605.1K | ||||||
| Net Cash Provided By Used In Investing Activities | -$661.0K | -$177.0K | $229.4M | ||||||
| Proceeds From Convertible Debt | $11.5M | $100.0K | |||||||
| Cost Of Goods And Service Excluding Depreciation Depletion And Amortization | $10.1M | $804.0K | $327.0K | $476.0K | $257.0K | $306.0K | |||
| Share Based Compensation | $7.6M | $11.0M | $346.0K | $337.0K | |||||
| Increase Decrease In Fair Value Of Convertible Notes | -$165.7M | -$15.4M | -$5.9M | -$4.7M | |||||
| Increase Decrease In Other Assets | -$102.3K | -$17.4K | -$17.7K | ||||||
| Payments To Acquire Property Plant And Equipment | $661.0K | $177.0K | |||||||
| Increase Decrease In Fair Value Of Warrant Liabilities | -$60.3M | $4.9M | -$3.5M | ||||||
| Increase Decrease In Accrued Liabilities | $242.9K | -$412.1K | |||||||
| Increase Decrease In Operating Lease Liability | -$152.0K | -$140.0K | |||||||
| Increase Decrease In Inventories | -$178.0K | $1.8M | |||||||
| Increase Decrease In Franchise Tax Payable | $92.1K | $50.0K | |||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$8.5M | -$33.0K | |||||||
| Increase Decrease In Other Operating Liabilities | -$234.0K | -$182.0K | |||||||
| Increase Decrease In Other Operating Assets | -$8.0K | -$170.0K | |||||||
| Increase Decrease In Accrued Compensation | $150.0K | $322.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 104.3M | 17.5M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 104.3M | 17.5M | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |
| Earnings Per Share Diluted | $-1.98 | $-3.50 | |||
| Earnings Per Share Basic | $-1.98 | $-3.50 | |||
| Common Stock Shares Outstanding | 122.0M | 48.4M | |||
| Common Stock Shares Issued | 122.0M | 48.4M | |||
| Common Stock Shares Authorized | 600.0M | 136.6M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 103.6M | 104.6M | 91.7M | 17.5M | 13.6M | 13.6M | ||||||
| Weighted Average Number Of Diluted Shares Outstanding | 103.6M | 104.6M | 91.7M | 17.5M | 13.6M | 13.6M | ||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Earnings Per Share Diluted | $-0.25 | $-0.28 | $-1.61 | $-1.47 | $-0.89 | $-1.23 | ||||||
| Earnings Per Share Basic | $-0.25 | $-0.28 | $-1.61 | $-1.47 | $-0.89 | $-1.23 | ||||||
| Common Stock Shares Outstanding | 106.8M | 98.9M | 98.8M | |||||||||
| Common Stock Shares Issued | 106.8M | 98.9M | 98.8M | |||||||||
| Common Stock Shares Authorized | 600.0M | 600.0M | 600.0M | |||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating Costs And Expenses | $4.5M | $3.0M | $1.3M | ||
| Investment Income Interest | $2.5M | $5.8M | $4.0M | ||
| Franchise Tax Expense | $206.3K | $344.3K | $202.9K | ||
| Additional Paid In Capital | $675.1M | $318.8M | $0.00 | $0.00 | $0.00 |
| Foreign Currency Transaction Gain Loss Before Tax | |||||
| Depreciation And Amortization | |||||
| Transaction Costs1 | |||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $37.5M | $3.8M | |||
| Stock Issued During Period Value Stock Options Exercised | $345.0K | $98.0K | |||
| Other Noncash Expense |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Costs And Expenses | $24.4M | $23.9M | $39.0M | $11.7M | $11.4M | $8.7M | $677.7K | $506.5K | $701.5K | $280.5K | $220.0K | $126.3K | $500.00 |
| Investment Income Interest | $638.3K | $625.9K | $628.1K | $910.4K | $823.7K | $3.1M | $1.3M | $394.0K | $29.4K | ||||
| Franchise Tax Expense | $50.0K | $50.0K | $56.3K | $50.0K | $50.0K | $194.3K | $122.0K | ||||||
| Additional Paid In Capital | $634.2M | $610.3M | $602.3M | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Foreign Currency Transaction Gain Loss Before Tax | -$88.0K | -$37.0K | -$29.0K | $31.0K | -$44.0K | -$49.0K | |||||||
| Depreciation And Amortization | $364.0K | $456.0K | $191.0K | $251.0K | $184.0K | $253.0K | |||||||
| Transaction Costs1 | $0.00 | $12.0M | $77.0K | $41.0K | $45.0K | ||||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $9.5M | $7.6M | $11.0M | $359.0K | $346.0K | $337.0K | |||||||
| Stock Issued During Period Value Stock Options Exercised | $18.0K | $38.0K | $42.0K | ||||||||||
| Other Noncash Expense | $150.0K | $153.0K |
Most recent annual filing with the SEC: March 24, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.